Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
ebi-a-GCST90093345 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis in patients positive for neutralising antibodies (antibody titre; IFN<U+03B2>-1b subcutaneous) | NA | 499 | 7,897,681 |
ebi-a-GCST90093344 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis in patients positive for neutralising antibodies (antibody titre; IFN<U+03B2>-1a subcutaneous and intramuscular) | NA | 477 | 7,476,531 |
ebi-a-GCST90011773 | 2021 | Ara-C drug response (AUC) | NA | 432 | 3,790,237 |
ebi-a-GCST90011776 | 2021 | Cisplatin drug response (IC50) | NA | 431 | 3,790,232 |
ebi-a-GCST90011775 | 2021 | Carboplatin drug response (IC50) | NA | 430 | 3,790,232 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: